机器人辅助与腹腔镜及开放手术治疗直肠癌合并造口形成的结局比较
基于PINC AI医疗数据库2013至2020年12787例择期直肠癌切除并造口患者的回顾性队列研究,比较机器人辅助手术(RAS)与腹腔镜(Lap)及开放手术(OS)的临床结局。RAS患者更可能接受回肠造口而非永久性结肠造口,且在回肠造口和永久性结肠造口亚组中,RAS均与更少的术后并发症和更好的恢复相关。
要点
- RAS较OS更可能行回肠造口而非永久性结肠造口(OR 1.53)。
- 回肠造口患者中,RAS较Lap减少肠梗阻和出血。
- 永久性结肠造口患者中,RAS较Lap减少再手术并提高回家出院率。
核心结论
- 直肠癌患者接受RAS更可能行回肠造口而非永久性结肠造口,且较Lap和OS恢复更佳。
研究设计与样本
- 回顾性队列研究,纳入PINC AI医疗数据库2013年1月至2020年12月12787例≥18岁择期直肠癌切除并造口患者。
- 采用多变量logistic回归(考虑医院聚类)比较造口类型,并构建逆概率治疗加权分析分别比较回肠造口和永久性结肠造口结局。
主要发现
- 共12787例患者(OS 5599例[43.8%],Lap 2872例[22.5%],RAS 4316例[33.7%])。
- 较OS,Lap(OR 1.29,p<0.001)和RAS(OR 1.53,p<0.001)更可能行回肠造口而非永久性结肠造口。
- 回肠造口患者中,RAS较Lap减少肠梗阻(OR 0.71,p<0.001)和出血(OR 0.50,p<0.001)。
- 回肠造口患者中,RAS较OS降低吻合口漏(OR 0.25,p<0.001)、减少出血(OR 0.51,p<0.001)和输血(OR 0.70,p=0.022)。
- 永久性结肠造口患者中,RAS较Lap减少肠梗阻(OR 0.72,p<0.001)、出血(OR 0.78,p=0.021)、30天再手术(OR 0.49,p<0.001)并提高回家出院率(OR 1.26,p=0.013)。
临床怎么用
- 在需造口的直肠癌切除中,RAS可能有利于避免永久性结肠造口并改善术后恢复。
- 对回肠造口或永久性结肠造口患者,RAS可考虑用于降低特定并发症和再手术风险。
局限性
- 回顾性数据库研究,可能存在未测量混杂。
- 仅纳入需造口的择期直肠癌切除患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite widespread adoption of robotic-assisted surgery (RAS) in rectal cancer resection, there remains limited knowledge of its clinical advantage over laparoscopic (Lap) and open (OS) surgery. We aimed to compare clinical outcomes of RAS with Lap and OS for rectal cancer. METHODS: We identified all patients aged ≥ 18 years who had elective rectal cancer resection requiring temporary or permanent stoma formation from 1/2013 to 12/2020 from the PINC AI™ Healthcare Database. We completed multivariable logistic regression analysis accounting for hospital clustering to compare ileostomy formation between surgical approaches. Next, we built inverse probability of treatment-weighted analyses to compare outcomes for ileostomy and permanent colostomy separately. Outcomes included postoperative complications, in-hospital mortality, discharge to home, reoperation, and 30-day readmission. RESULTS: A total of 12,787 patients (OS: 5599 [43.8%]; Lap: 2872 [22.5%]; RAS: 4316 [33.7%]) underwent elective rectal cancer resection. Compared to OS, patients who had Lap (OR 1.29, p < 0.001) or RAS (OR 1.53, p < 0.001) were more likely to have an ileostomy rather than permanent colostomy. In those with ileostomy, RAS was associated with fewer ileus (OR 0.71, p < 0.001) and less bleeding (OR 0.50, p < 0.001) compared to Lap. In addition, RAS was associated with lower anastomotic leak (OR 0.25, p < 0.001), less bleeding (OR 0.51, p < 0.001), and fewer blood transfusions (OR 0.70, p = 0.022) when compared to OS. In those patients who had permanent colostomy formation, RAS was associated with fewer ileus (OR 0.72, p < 0.001), less bleeding (OR 0.78, p = 0.021), lower 30-day reoperation (OR 0.49, p < 0.001), and higher discharge to home (OR 1.26, p = 0.013) than Lap, as well as OS. CONCLUSION: Rectal cancer patients treated with RAS were more likely to have an ileostomy rather than a permanent colostomy and more enhanced recovery compared to Lap and OS.
引用
- Goldstone RN, Francone T, Milky G, et al. Outcomes comparison of robotic-assisted versus laparoscopic and open surgery for patients undergoing rectal cancer resection with concurrent stoma creation. Surg Endosc. 2024. PMID: 38942946. doi:10.1007/s00464-024-10996-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。